FDA inspection
Shandong Ruiying Pioneer Pharmaceutical Co., Ltd: FDA inspection ending Mar 22, 2019
FDA inspection 1086433 · Voluntary Action Indicated (VAI) · Heze
Key facts
| Inspection ID | 1086433 |
|---|---|
| Firm | Shandong Ruiying Pioneer Pharmaceutical Co., Ltd |
| FEI number | 3008320758 |
| Address | 166 Taiyuanlu, Mudan |
| City | Heze |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Mar 22, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data